MedDataX Logo

Outcomes of Severe Sepsis Patients in Surgical Intensive Care Units

NCT ID: NCT01919138

Last Updated: 2014-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

762 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective review of the outcomes of severe sepsis patients in Surgical Intensive Care Unit of National Taiwan University Hospital from January 1, 2009 to December 31, 2011.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Application of SERS and Metabolomics in Sepsis

NCT02213237

Sepsis
UNKNOWN

Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation

NCT01362829

Sepsis
COMPLETED

Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis

NCT02871895

Systemic Inflammatory Response Syndrome (SIRS) Sepsis Severe Sepsis +2 more
UNKNOWN

Endotoxin Activity Assay and Microcirculation in Severe Sepsis

NCT02452138

Sepsis
UNKNOWN

Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient

NCT04105400

Sepsis, Severe
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients suffered from severe sepsis or septic shock have a mortality of 20\~54%. It is major healthcare problems, affecting millions of individuals around the world each year. An international group of experts in the diagnosis and management of infection and sepsis, representing 11 organizations, published the first internationally accepted guidelines that the bedside clinician could use to improve outcomes in severe sepsis and septic shock in 2004, and further outcome was reported in 2008. Lots of medical centers have joined the Surviving Sepsis Campaign and follow the latest guideline. Many reports have shown that Surviving Sepsis Campaign Guideline can reduce patient mortality.

In surgical intensive care units of National Taiwan University Hospital (NTUH), the Surviving Sepsis Campaign Guideline was conducted since 2009. Our purpose is to investigate the characteristics and outcomes of severe sepsis patient in surgical intensive care units of NTUH by retrospective review of medical chart.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Sepsis Septic Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

severe sepsis, septic shock

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients were diagnosed as severe sepsis in Surgical Intensive Care units of National Taiwan University Hospital

Exclusion Criteria

* \< 20 years old
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Chang Yeh, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Anesthesiology, National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201305085RINC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Severe Sepsis/Septic Shock on Admission to the General Surgical ICU
NCT01363635 UNKNOWN
Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal Sepsis
NCT06756750 COMPLETED
A Prospective Observational Study of Sepsis
NCT05309889 UNKNOWN
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 COMPLETED NA
Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients
NCT06363149 RECRUITING
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 COMPLETED
A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome
NCT01775956 UNKNOWN
The Efficacy of High-flow Nasal Cannula Oxygen Therapy in Sepsis Patients
NCT04560842 UNKNOWN NA
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 TERMINATED
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 COMPLETED
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 UNKNOWN
Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis
NCT03506152 COMPLETED
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 UNKNOWN
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
NCT05692128 UNKNOWN
Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis
NCT07245966 COMPLETED
Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
NCT04564508 UNKNOWN
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 UNKNOWN
Resuscitation Failure, Oxidative Stress, and Necroptosis as Mortality Predictor in Septic Patient
NCT04169412 COMPLETED
The Relation Between Triglyceride- Glucose Index, Procalcitonin and Cardiac Affection in Septic Shock.
NCT06518083 NOT_YET_RECRUITING
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905 COMPLETED
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198 NOT_YET_RECRUITING
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 UNKNOWN
Impact of the Introduction of a Performance Improvement Program on the Initial Management of Sepsis and Septic Shock in Adults in the Emergency Department: a Before-and-after Study (IPA-SOS)
NCT06657625 ENROLLING_BY_INVITATION
Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery
NCT02189434 COMPLETED
Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock
NCT01685112 UNKNOWN